TARDBP and Alzheimer disease: Finally, we assessed the sensitivity of the biomarkers for the presence of common non-AD pathologies at autopsy, including cerebral amyloid angiopathy (CAA), Lewy body (LB) pathology, and limbic TAR DNA-binding protein 43 (TDP-43) pathology.